Introduction On Tuesday, President Donald Trump signed a significant memorandum aimed at increasing transparency in pharmaceutical advertising. This move places pressure on drug companies to adhere to established advertising laws, particularly on digital platforms like social media. The administration’s initiative signals a commitment to ensuring that consumers receive clear and honest information regarding pharmaceuticals, which…